Heart Attack News and Research

RSS

Celebrex suspension

The National Institutes of Health (NIH) announced that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex™ Pfizer, Inc.) for all participants in a large colorectal cancer prevention clinical trial conducted by the National Cancer Institute (NCI).

19 Dec 2004

High pressure work deadlines boost heart attack risk six-fold

A high pressure work deadline boosts the chances of a heart attack within the next 24 hours by a factor of six, reveals research in the Journal of Epidemiology and Community Health.

13 Dec 2004

Risk of having a heart attack is elevated in the weeks after stopping use of nonsteroidal anti-inflammatory drugs

The risk of having a heart attack is elevated in the weeks after stopping use of nonsteroidal anti-inflammatory drugs, according to an article in the December issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Dec 2004

Greater risk of heart attack associated with Vioxx than Celebrex

In the first epidemiological study designed and executed specifically to determine the heart-attack risk associated with COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex), researchers at the University of Pennsylvania School of Medicine found a greater risk of heart attack associated with Vioxx than Celebrex, although neither of the two drugs showed a statistically significant elevated risk of heart attack relative to people who did not use the drugs.

8 Dec 2004

New insight into anticoagulation therapies

Anticoagulation therapies, or treatments that reduce the amount of clotting factors in the blood, are quite common and used for a variety of reasons.

6 Dec 2004

Heart Hospital begins experimental cell therapy

Physicians at the Heart Hospital became the first team in the UK to treat a patient with an experimental new therapy designed to repair damage to cardiac muscle resulting from a heart attack. If successful, this treatment would give doctors the ability to improve the hearts of people with heart failure, rather than just treating the symptoms.

6 Dec 2004

Heart researchers have used gene therapy to bring failing rat hearts back to normal

Scientists led by Walter Koch, Ph.D., director of the Center for Translational Medicine in the Department of Medicine in Jefferson Medical College of Thomas Jefferson University in Philadelphia, used a virus to insert the gene for a protein called S100A1 into failing rat hearts.

4 Dec 2004

African Americans more likely to carry genetic variants known to stimulate inflammatory response

Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).

1 Dec 2004

Type 1 diabetes could be prevented by a new nasal insulin vaccine

A world-leading medical trial conducted in Melbourne suggests that the onset of type 1 diabetes could be prevented in many at-risk people by a new nasal insulin vaccine.

29 Nov 2004

Elevated BMI may not increase risk of death among men with heart attack or stroke

BMI, or body mass index, is considered an indicator of both mortality and heart attack risk among middle-aged and older men free of major diseases. However, the impact of BMI on mortality in men who have already had a heart attack or stroke has not been clearly established.

29 Nov 2004

Weight gain beginning in childhood can lead to an enlarged heart

Weight gain beginning in childhood can lead to an enlarged heart by early adulthood, researchers reported in Circulation: Journal of the American Heart Association.

24 Nov 2004

Bypass surgery on a beating heart is an excellent option for many patients with blocked heart arteries

Bypass surgery on a beating heart is an excellent option for many patients with blocked heart arteries, according to a study in Circulation: Journal of the American Heart Association.

24 Nov 2004

Chylomicrons may be as dangerous or more dangerous than low-density lipoprotein (LDL) cholesterol

You may not yet have heard of chylomicrons, but a nutritional scientist at the University of Alberta believes you will soon--especially if you care about preventing a stroke or heart attack.

24 Nov 2004

Deaths caused by cardiovascular disease have decreased over the last 50 years

Adults with diabetes have experienced a 50 percent decline in the incidence rate for cardiovascular disease events in recent decades, according to a report in the November 24 issue of JAMA.

24 Nov 2004

Obesity could increase a person’s risk for atrial fibrillation

New research indicates that being obese could increase a person’s risk for atrial fibrillation, the most common irregular heart rhythm, by 50 percent, according to work published in the November 24 issue of JAMA.

24 Nov 2004

Having diabetes raises a woman's risk of having a heart attack to nearly 10 times

Having diabetes raises a woman's risk of having a heart attack to nearly 10 times that of other women, according to a study in the December issue of Diabetes Care. The study also describes why women with diabetes are at much higher risk than men with diabetes when it comes to having cardiac events.

23 Nov 2004

Heart Attack News and Research

Celebrex suspension

High pressure work deadlines boost heart attack risk six-fold

Risk of having a heart attack is elevated in the weeks after stopping use of nonsteroidal anti-inflammatory drugs

Greater risk of heart attack associated with Vioxx than Celebrex

New insight into anticoagulation therapies

Heart Hospital begins experimental cell therapy

Heart researchers have used gene therapy to bring failing rat hearts back to normal

African Americans more likely to carry genetic variants known to stimulate inflammatory response

Type 1 diabetes could be prevented by a new nasal insulin vaccine

Elevated BMI may not increase risk of death among men with heart attack or stroke

Weight gain beginning in childhood can lead to an enlarged heart

Bypass surgery on a beating heart is an excellent option for many patients with blocked heart arteries

Chylomicrons may be as dangerous or more dangerous than low-density lipoprotein (LDL) cholesterol

Deaths caused by cardiovascular disease have decreased over the last 50 years

Obesity could increase a person’s risk for atrial fibrillation

Having diabetes raises a woman's risk of having a heart attack to nearly 10 times

Some hospitals face financial upheaval under new NHS payment system

Startling new blood pressure findings - atherosclerosis slowed

Acetaminophen shows positive cardioprotective effects In heart attack, arrhythmia

Millions of people threatened by the diabetes time bomb

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News